Renin and the (pro)renin receptor in the renal collecting duct: Role in the pathogenesis of hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 42, Issue 1, 2015, Pages 14-21

  Gonzalez, Alexis A ^a   Prieto, Minolfa C ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II dependent hypertension; Collecting duct; Prorenin receptor; Renin; Renin angiotensin system

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PRORENIN; PRORENIN RECEPTOR; RENIN; VASCULOTROPIN; ATP6AP2 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; HUMAN; HYPERTENSION; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; MESANGIUM CELL; NEPHRON; NONHUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; ANIMAL; PHYSIOLOGY;

ANIMALS; HUMANS; HYPERTENSION; KIDNEY TUBULES, COLLECTING; RECEPTORS, CELL SURFACE; RENIN; RENIN-ANGIOTENSIN SYSTEM; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84919598546     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12319     Document Type: Review

References (73)

1. Borensztein P, Germain S, Fuchs S, Philippe J, Corvol P, Pinet F. cis-Regulatory elements and trans-acting factors directing basal and cAMP-stimulated human renin gene expression in chorionic cells. Circ. Res. 1994; 74: 764-73.
2. Castrop H, Hocherl K, Kurtz A, Schweda F, Todorov V, Wagner C. Physiology of kidney renin. Physiol. Rev. 2010; 90: 607-73.
3. Muller MW, Todorov V, Kramer BK, Kurtz A. Angiotensin II inhibits renin gene transcription via the protein kinase C pathway. Pflügers Arch. 2002; 444: 499-505.
4. Seikaly MG, Arant BS Jr, Seney FD Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J. Clin. Invest. 1990; 86: 1352-7.
5. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H et al. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 2004; 44: 223-9.
6. 1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am. J. Physiol. Renal. Physiol. 2005; 289: F632-7.
7. Prieto-Carrasquero MC, Botros FT, Pagan J et al. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip Goldblatt hypertensive rats. Hypertension 2008; 51: 1590-6.
8. Prieto-Carrasquero MC, Botros FT, Kobori H, Navar LG. Collecting duct renin: A major player in angiotensin II-dependent hypertension. J. Am. Soc. Hypertens. 2009; 3: 96-104.
9. Prieto MC, Gonzalez AA, Navar LG. Evolving concepts on regulation and function of renin in distal nephron. Pflügers Arch. 2013; 465: 121-32.
10. Rohrwasser A, Morgan T, Dillon HF et al. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 1999; 34: 1265-74.
11. Rohrwasser A, Ishigami T, Gociman B et al. Renin and kallikrein in connecting tubule of mouse. Kidney Int. 2003; 64: 2155-62.
12. Gonzalez AA, Liu L, Lara LS, Seth DM, Navar LG, Prieto MC. Angiotensin II stimulates renin in inner medullary collecting duct cells via protein kinase C and independent of epithelial sodium channel and mineralocorticoid receptor activity. Hypertension 2011; 57: 594-9.
13. Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 2001; 37: 1329-1335.
14. Gonzalez-Villalobos RA, Satou R, Ohashi N et al. Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am. J. Physiol. Renal. Physiol. 2010; 298: F150-7.
15. Nguyen G, Contrepas A. Physiology and pharmacology of the (pro)renin receptor. Curr. Opin. Pharmacol. 2008; 8: 127-32.
16. Nguyen G, Muller DN. The biology of the (pro)renin receptor. J. Am. Soc. Nephrol. 2010; 21: 18-23.
17. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 2002; 109: 1417-27.
18. Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 1996; 50: 1897-903.
19. Nguyen G, Danser AH. The (pro)renin receptor: Therapeutic consequences. Expert Opin. Invest. Drugs 2006; 15: 1131-5.
20. Navar LG, Harrison-Bernard LM. Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension. Hypertens. Res. 2000; 23: 291-301.
21. Navar LG, Mitchell KD, Harrison-Bernard LM, Kobori H, Nishiyama A. Intrarenal angiotensin II levels in normal and hypertensive states. J. Renin Angiotensin Aldost. Syst 2001; 2 (Suppl.): S176-84.
22. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39: 316-22.
23. Nishiyama A, Seth DM, Navar LG. Angiotensin II type 1 receptor-mediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension. J. Hypertens. 2003; 21: 1897-903.
24. Wang C-T, Navar LG, Mitchell KD. Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats. J. Hypertens. 2003; 21: 353-60.
25. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension 2011; 57: 355-62.
26. Komlosi P, Fuson AL, Fintha A et al. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 2003; 42: 195-9.
27. Casarini DE, Boim MA, Stella RCR, Krieger-Azzolini MH, Krieger JE, Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am. J. Physiol. Renal. Physiol. 1997; 272: F405-9.
28. Gonzalez-Villalobos RA, Billet S, Kim C et al. Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J. Am. Soc. Nephrol. 2011; 22: 449-59.
29. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J. Am. Soc. Nephrol. 2002; 13: 1131-5.
30. Crowley SD, Gurley SB, Herrera MJ et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl Acad. Sci. USA 2006; 103: 17985-90.
31. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 2002; 61: 579-85.
32. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension 2003; 41: 42-9.
33. 1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 2004; 43: 1126-32.
34. Ingelfinger JR, Jung F, Diamant D et al. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: Autocrine ANG II feedback. Am. J. Physiol. Renal. Physiol. 1999; 276: F218-27.
35. Kurtz A, Wagner C. Cellular control of renin secretion. J. Exp. Biol. 1999; 202: 219-25.
36. Shao W, Seth DM, Navar LG. Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats. Am. J. Physiol. Renal. Physiol. 2009; 296: F1067-71.
37. Shao W, Seth DM, Navar LG. Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats. Hypertension 2010; 56: 378-83.
38. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H. The (pro)renin receptor and the kidney. Semin. Nephrol. 2007; 27: 524-8.
39. Ichihara A, Sakoda M, Kurauchi-Mito A, Kaneshiro Y, Itoh H. Involvement of (pro)renin receptor in the glomerular filtration barrier. J. Mol. Med. 2008; 86: 629-35.
40. Ichihara A. (Pro)renin receptor and autophagy in podocytes. Autophagy 2012; 8: 271-2.
41. Gonzalez AA, Lara LS, Luffman C, Seth DM, Prieto MC. Soluble form of the (pro)renin receptor is augmented in the collecting duct and urine of chronic angiotensin II-dependent hypertensive rats. Hypertension 2011; 57: 859-64.
42. Satofuka S, Ichihara A, Nagai N et al. (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes 2009; 58: 1625-33.
43. Deinum J, Ronn B, Mathiesen E, Derkx FH, Hop WC, Schalekamp MA. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia 1999; 42: 1006-10.
44. Kaneshiro Y, Ichihara A, Takemitsu T et al. Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int. 2006; 70: 641-6.
45. Ichihara A, Hayashi M, Kaneshiro Y et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the 'handle' region for nonproteolytic activation of prorenin. J. Clin. Invest. 2004; 114: 1128-35.
46. Kang JJ, Toma I, Sipos A, Meer EJ, Vargas SL, Peti-Peterdi J. The collecting duct is the major source of prorenin in diabetes. Hypertension 2008; 51: 1597-604.
47. Nguyen G, Burckle CA, Sraer JD. Renin/prorenin-receptor biochemistry and functional significance. Curr. Hypertens. Rep. 2004; 6: 129-32.
48. Huang J, Siragy HM. Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (pro)renin receptor expression. Endocrinology 2009; 150: 5557-65.
49. He M, Zhang L, Shao Y et al. Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur. J. Pharmacol. 2009; 606: 155-61.
50. Kanda A, Noda K, Saito W, Ishida S. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy. Diabetologia 2012; 55: 3104-13.
51. Takemitsu T, Ichihara A, Kaneshiro Y et al. Association of (pro)renin receptor mRNA expression with angiotensin-converting enzyme mRNA expression in human artery. Am. J. Nephrol. 2009; 30: 361-70.
52. Gonzalez AA, Luffman C, Bourgeois CR, Vio CP, Prieto MC. Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (pro)renin receptor in rat renal inner medullary cells. Hypertension 2013; 61: 443-9.
53. Prieto MC, Williams DE, Liu L, Kavanagh KL, Mullins JJ, Mitchell KD. Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension. Am. J. Physiol. Renal. Physiol. 2011; 300: F581-8.
54. Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 2009; 53: 1077-82.
55. Vio CP, Jeanneret VA. Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases. Kidney Int. Suppl. 2003; 86: 57-63.
56. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J. Am. Soc. Nephrol. 2001; 12: 431-9.
57. Kobori H, Ohashi N, Katsurada A et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J. Am. Soc. Hypertens. 2008; 2: 349-54.
58. Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG. Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J. Hypertens. 2010; 28: 1422-8.
59. van den Heuvel M, Batenburg WW, Jainandunsing S et al. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. J. Hypertens. 2011; 29: 2147-55.
60. Nguyen G, Blanchard A, Curis E et al. Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity. Hypertension 2014; 63: 297-302.
61. Franken AA, Derkx FH, Blankestijn PJ et al. Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus. Diabetes Metab. 1992; 18: 137-43.
62. Ichihara A, Kaneshiro Y, Takemitsu T et al. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J. Am. Soc. Nephrol. 2006; 17: 2495-503.
63. Li W, Peng H, Cao T et al. Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension. Hypertension 2012; 59: 1188-94.
64. Krebs C, Hamming I, Sadaghiani S et al. Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int. 2007; 72: 725-30.
65. Kaneshiro Y, Ichihara A, Sakoda M et al. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J. Am. Soc. Nephrol. 2007; 18: 1789-95.
66. Komers R. Renin inhibition in the treatment of diabetic kidney disease. Clin. Sci. 2013; 124: 553-66.
67. Nguyen G, Burckle C, Sraer JD. The renin receptor: The facts, the promise and the hope. Curr. Opin. Nephrol. Hypertens. 2003; 12: 51-5.
68. +-ATPase in the kidney. Hypertension 2009; 54: 261-9.
69. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J. Am. Soc. Nephrol. 2002; 13: 2207-12.
70. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002; 39: 129-34.
71. Liu L, Gonzalez AA, McCormack M et al. Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am. J. Physiol. Renal. Physiol. 2011; 301: F1195-201.
72. Zhao D, Navar LG. Acute angiotensin II infusions elicit pressure natriuresis in mice and reduce distal fractional sodium reabsorption. Hypertension 2008; 52: 137-42.
73. Zhao D, Seth DM, Navar LG. Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension 2009; 54: 120-6.